Alixorexton is the company’s novel, investigational, oral, selective orexin 2 receptor agonist in phase 2 development for the treatment of narcolepsy type 1, narcolepsy type 2, and idiopathic hypersomnia.
Read More
The AIO Breathe is cleared for children as young as 6 years old with mild to moderate OSA.
Read More
The SleepTech Talk co-host connected with the mail-order oral appliance therapy company as a patient first.
Read More
Its upper and lower splints can be incrementally adjusted with interchangeable Z-Links on each side.
Read More
The new Panthera DUO program provides two identical oral appliances per patient at a bundled price, helping clinicians ensure uninterrupted sleep apnea treatment and fewer emergency remakes.
Read More